ROSSETTI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 558
EU - Europa 486
AS - Asia 148
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.195
Nazione #
US - Stati Uniti d'America 558
SE - Svezia 127
UA - Ucraina 120
IE - Irlanda 71
SG - Singapore 70
DE - Germania 48
CN - Cina 36
IT - Italia 35
FI - Finlandia 27
HK - Hong Kong 22
RU - Federazione Russa 16
VN - Vietnam 14
GB - Regno Unito 13
BE - Belgio 7
CZ - Repubblica Ceca 6
FR - Francia 4
AT - Austria 3
CH - Svizzera 3
PL - Polonia 3
AZ - Azerbaigian 1
BR - Brasile 1
EU - Europa 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
NL - Olanda 1
PK - Pakistan 1
RO - Romania 1
TR - Turchia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.195
Città #
Chandler 140
Dublin 71
Jacksonville 64
Singapore 57
San Mateo 44
Ann Arbor 42
Boardman 31
Hong Kong 22
Wilmington 20
Medford 19
Princeton 19
Santa Clara 19
Munich 18
Andover 14
Dong Ket 14
Altamura 12
Lawrence 11
Woodbridge 11
Helsinki 8
Saint Petersburg 8
Beijing 7
Brussels 7
Perugia 7
Brno 6
Los Angeles 5
Falls Church 4
San Paolo di Civitate 4
Auburn Hills 3
Des Moines 3
Norwalk 3
Amelia 2
Bari 2
Frankfurt Am Main 2
Houston 2
Nürnberg 2
Baku 1
Bucu 1
Corridonia 1
Dallas 1
Den Haag 1
Frankfurt am Main 1
Hanover 1
Islamabad 1
Izmir 1
Moscow 1
Mountain View 1
Pacatuba 1
Rome 1
Seoul 1
Shanghai 1
Vienna 1
Totale 719
Nome #
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 117
Administration of neutral protamine Hagerdon insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. 97
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 84
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 77
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 76
Uso dell’analogo ad azione rapida lispro con l’analogo ad azione ritardo glargine nel trattamento intensivo del T1DM 70
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs 66
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 64
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans 59
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting analogue at mealtime. A three month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. 58
Il nuovo analogo dell’insulina ad azione ritardata glargine: caratteristiche ed uso terapeutico nel diabete mellito 55
Intensive replacement of basal insulin in patients with Type 1 diabetes mellitus given rapid-acting insulin analogue at meal-time: a three-month comparison between administration of NPH four times daily and glargine insulin at dinner or bedtime. 51
null 49
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. 49
Glucagon: the effects of its excess and deficiency on insulin action 49
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. 49
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 45
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. 44
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 40
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin 28
Totale 1.227
Categoria #
all - tutte 4.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.942


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 0 0 0 0 0 2 16 7 4 15
2020/2021252 1 20 18 17 55 24 19 2 36 14 26 20
2021/2022184 7 34 4 25 6 2 2 59 3 3 18 21
2022/2023328 21 64 3 41 33 37 0 16 105 0 7 1
2023/2024123 7 19 4 2 1 0 15 0 8 1 36 30
2024/2025123 5 25 4 44 35 7 3 0 0 0 0 0
Totale 1.227